Association of leucine pathway metabolites with moyamoya disease and its clinical phenotypes
Leucine and its metabolic derivatives have emerged as promising candidates for biomarker discovery in cardio-cerebrovascular diseases. Despite this, their involvement in the pathophysiology and phenotypic expression of moyamoya disease (MMD) remains largely unexplored. This investigation therefore sought to delinea...